Healthcare

Healthcare has always required a multi-disciplinary approach encompassing expertise in life sciences, pharmaceuticals, medical devices, materials, electronics, software and more.

With more than 200 attorneys covering every technology as well as lawyers dealing with life cycle commercial agreements, HGF is ideally placed to offer the best combination of industry-specific expertise for any client in the healthcare sector. HGF represents the full spectrum of healthcare clients from global pharmaceutical companies to SMEs and start-ups.

This cross-disciplinary approach is more important than ever with the adoption of AI and other digital technologies into all aspects of healthcare innovation. With developments in personalised medicine, use of AI, big data, robotics, VR, new drug delivery systems and CRISPR technology as well as global healthcare challenges requiring rapid and collaborative response, HGF’s large multidisciplinary teams are the ideal support in this rapidly evolving and complex sector.

MRI scan
Lab technician

Our healthcare specialists

We’ve built our business by recruiting and developing specialists, not generalists. When it comes to protecting your ideas and business, you want to know you’re working with the best – people who truly understand your sector and the potential of your IP.

HGF’s team has healthcare professionals from an array of academic and business backgrounds. Our team-based approach ensures our clients benefit from the very best strategic advice from people who understand not only the legal environment but also the practical side of your business.

Let's talk

If you would like to discuss how HGF could help you, contact one of our healthcare specialists.

Latest news

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

Agritech Thymes: Unlocking the Soil Microbiome: Driving Agritech Innovation in the UK

The UK offers an ideal platform for harnessing the untapped potential of soil and plant microorganisms. Although much of my professional experience has focused on the human microbiome, I have …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article